Please ensure Javascript is enabled for purposes of website accessibility

CDC Releases List of Conditions That Increase the Risk of Severe Coronavirus Illness

By Prosper Junior Bakiny - Mar 12, 2020 at 10:48AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Those at highest risk should take precautions.

The situation surrounding COVID-19 is only getting worse. Over the past 24 hours, the World Health Organization (WHO) officially declared COVID-19 a pandemic, and U.S. President Donald Trump opted to ban most travel from Europe. Given these developments, all of us need to take steps to mitigate the spread of COVID-19, and this is particularly critical for those with underlying health conditions who are most at risk of experiencing a severe illness if they contract the disease.

The U.S. Centers for Disease Control and Prevention (CDC) recently released a list of medical conditions that increase the risk of severe manifestation of COVID-19. This list includes the following conditions: 

  • Blood disorders
  • Chronic kidney disease
  • Compromised immune system
  • Pregnancy (current or recent)
  • Endocrine disorders (such as diabetes)
  • Metabolic disorders
  • Heart disease
  • Lung disease
  • Neurological conditions 
Microscopic picture of the Coronavirus

Image Source: Getty Images.

The race to find a vaccine or a treatment continues

So far, no vaccine or treatment has been approved by health regulators for the new coronavirus. And while a bit more than of half of all people with confirmed COVID-19 infections so far have already recovered, those who have died from it have mostly been older adults and those with underlying health conditions. Currently, biotech companies such as Inovio Pharmaceuticals (INO -0.48%), Moderna (MRNA 2.58%), and Novavax (NVAX -1.17%) are trying to develop vaccines for COVID-19. And Gilead Sciences (GILD 0.63%) is the leader in the race to find a treatment for the rapidly spreading disease. The CDC recently said that Gilead's antiviral drug remdesivir is being used to treat some COVID-19 patients, but it isn't yet clear how effective it is. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$62.73 (0.63%) $0.39
Novavax, Inc. Stock Quote
Novavax, Inc.
NVAX
$63.54 (-1.17%) $0.75
Inovio Pharmaceuticals, Inc. Stock Quote
Inovio Pharmaceuticals, Inc.
INO
$2.06 (-0.48%) $0.01
Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$159.56 (2.58%) $4.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
322%
 
S&P 500 Returns
113%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.